Visioneering Technologies, Inc. Reports Earnings Results for the Half Year Ended June 30, 2021
August 19, 2021 at 11:31 pm
Share
Visioneering Technologies, Inc. announced earnings results for the half year ended June 30, 2021. For the half year, the company announced sales was USD 3.111 million compared to USD 2.034 million a year ago. Operating loss was USD 4.028 million compared to USD 5.169 million a year ago. Net loss was USD 1.486 million compared to USD 5.174 million a year ago.
Visioneering Technologies, Inc. is a medical device company. The Company is primarily engaged in the design, manufacture, sale and distribution of a contact lens, the NaturalVue Multifocal 1 Day (NaturalVue MF) contact lens. The Company operates through two segments: North America and Europe / Asia-Pacific. The North America segment includes its operations in the United States and Canada. The Europe/Asia-Pacific segment includes its operations outside of North America. Its flagship product is the NaturalVue (etafilcon A) Multifocal 1 Day Contact Lens for adults with Presbyopia and children with Myopia. The Company sells its contact lenses in the United States, Europe, Australia, New Zealand, Hong Kong, Singapore, Canada and Malaysia. The Company manages the warehousing and distribution of its products through a contract with a third-party logistics provider (the 3PL).
VISIONEERING TECHNOLOGIES, INC. 
